Sbir topic 255
Ended Definitive Contract Awarded Last action
- Contract number
- HHSN261200900060C
- Awardee
-
Medigen, Inc. UEI MGLJHKGKWBL3
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $89,871
Award facts
- Opportunity
-
- PHS20091 Solicitation number
- Amend Description to Delete Requirements Award Notice · Posted Jul 17, 2008
- Contract value 100% obligated
- $89,871.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 27 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Frederick, MD 21701, USA
- Research
- SBIR Program Phase I Action
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Vendor Address Change | $0 | |
| Other Administrative Action | $0 | |
| Original award | $89,871 |
About this award
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services. The contract, valued at $89,871, was awarded to Medigen, Inc., a biotechnology company that specializes in vaccine development and manufacturing. The contract has a firm fixed price pricing type and an ultimate completion date of May 30, 2010. Medigen has received numerous federal grants and contracts from NIH and other agencies to support its work on novel, live-attenuated vaccines for diseases such as Venezuelan Equine Encephalitis, Chikungunya, and influenza. This specific contract is a SBIR Phase I action, which supports early-stage research and development of innovative technologies with potential for commercialization.
Quick answers
Who was awarded contract HHSN261200900060C?
HHSN261200900060C was awarded to Medigen, Inc. by National Cancer Institute (National Institutes of Health) on September 30, 2009.
How much is contract HHSN261200900060C worth?
The government has obligated $89,871 on HHSN261200900060C.
Was contract HHSN261200900060C competed?
The extent of competition for HHSN261200900060C was full and open competition after exclusion of sources. The government received 27 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award